Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News NervGen Pharma Corp V.NGEN

Alternate Symbol(s):  NGENF

Healthcare Biotechnology
NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis, and Alzheimer's disease. It operates in a single segment, which is the research and development of pharmaceutical drugs.


Stock Price Chart (TSXV:NGEN)

Fundamentals Snapshot (TSXV:NGEN)

Current News (TSXV:NGEN)

NervGen Pharma Grants Stock Options

Newsfile 6 days ago

NervGen Pharma Announces Results of Annual General Meeting of Shareholders

Newsfile 10 days ago

NervGen Pharma (TSXV:NGEN) marches towards Phase 1b/2a clinical trial

Jocelyn Aspa May 15, 2023

NervGen Pharma Reports Q1 2023 Results and Provides Operational Update Including Clinical Trials of Proprietary NVG-291

Newsfile May 15, 2023

NervGen Pharma Presenting Phase 1b/2a Study Design at American Spinal Injury Association 50th Annual Scientific Meeting

Newsfile April 13, 2023

NervGen Pharma (TSXV:NGEN) appoints Michael Kelly as President and CEO

Brieanna McCutcheon  April 10, 2023

NervGen Pharma Appoints Michael Kelly as President & Chief Executive Officer

Newsfile April 10, 2023

NervGen Pharma (TSXV:NGEN) releases year-end operational highlights

Brieanna McCutcheon  March 30, 2023

NervGen Pharma Reports 2022 Year End Results and Provides Operational Update Including Plans to Initiate Phase 1b/2a Clinical Trial of Proprietary NVG-291 in Q3 2023

Newsfile March 30, 2023
View More News ››

Opinion & Analysis (TSXV:NGEN)

NervGen Pharma: A “Blockbuster Drug” in the Making?

Stockhouse Editorial June 28, 2021

Alzheimer’s Breakthrough: Why the Experts are Betting on NervGen

Stockhouse Editorial April 7, 2021

Cracking the Code to Society’s Most Feared Disease

Stockhouse Editorial February 10, 2020
View More Opinion ››

Bullboard Posts (TSXV:NGEN)

Biogen Explodes Higher After Potential Mega Blockbuster Alzh

Biogen Explodes Higher After Potential Mega Blockbuster Alzheimer's Drug Succeeds (yahoo.com)
greenland - September 28, 2022

Incredible news! Unbelievable that this board is not going

I agree with the assessment from the last news release. Best stock out there, but apparently little known. The stock is up nearly 25...
curious924 - July 28, 2022

NervGen Pharma’s NVG-291-R Demonstrates Significant Function

NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Repair From a Stroke 7 Days After Onset in Landmark Preclinical Study by...
greenland - July 28, 2022

RE:NervGen Article is out today, link below

No one is here.  Best stock have ever found and it is that way because people do not know about it. https://ceo.ca/  article...
Geodan2 - May 5, 2022

NervGen Article is out today, link below

Article published https://ceo.ca/@geodan/nervgen-regenerates-neurons-what-is-a-drug-that-reverses-paralysis-ms-stroke-and-alzheimers...
Geodan2 - May 4, 2022

This has 1,000 bagger potential, article coming next week

 NervGen Regenerates Neurons, What Is A Drug That Reverses Paralysis, MS, Stroke And Alzheimer's Worth? Apr. 23, 2022 7:17 PM ET...
Geodan2 - April 29, 2022
View more Bullboard ››

i3 Energy Plc.

i3 Energy Plc.

i3 Energy is an oil and gas Company with a low cost, diversified, growing production base in Canada's most prolific ...
View More »